DeepNewz, mobile.

People-sourced. AI-powered. Unbiased News.

Screenshot of DeepNewz app showing story detail view.

Screenshot of DeepNewz app showing story list view.

Kisunla News

FDA Approves New Dosing for Eli Lilly’s Kisunla to Reduce Brain Swelling; U.K. NHS Rejects Drug, EMA Recommends Approval; Leqembi Shows Four-Year Benefit

13

5 days ago

Lilly Alzheimer’s Drug Donanemab Wins EMA Panel Backing

6

8 days ago

Will we have a treatment for Alzheimer's disease that halts the progression of the disease by 2035?

Nov 13, 12:49 PMJan 1, 10:59 PM

47.99%chance

5119

OptionVotes

YES

NO

104

96

Latest stories

Jul 28, 2025
Jul 28, 2025
Europe
Britain
Pharma
FDA Approves New Dosing for Eli Lilly’s Kisunla to Reduce Brain Swelling; U.K. NHS Rejects Drug, EMA Recommends Approval; Leqembi Shows Four-Year Benefit
Authors
13
5 days ago
Jul 25, 2025
Jul 25, 2025
Europe
Pharma
Science
Lilly Alzheimer’s Drug Donanemab Wins EMA Panel Backing
Authors
6
8 days ago

Join our channels

Get the latest stories live on any device.

WhatsApp
Top Stories
Join
Telegram
Top Stories
Join